Cited 0 time in
Total synthesis of (±)-galanthamine and related natural products with the regioselective Pd-catalyzed coupling reactions of 3,5-dibromo-2-pyrone
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | 조천규 | - |
| dc.date.accessioned | 2021-08-04T03:24:20Z | - |
| dc.date.available | 2021-08-04T03:24:20Z | - |
| dc.date.issued | 2006-04-20 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/70496 | - |
| dc.description.abstract | Galanthamine is the parent member of the galanthamine-type amaryllidaceae alkaloids, which has potent inhibitory activity against acetylcholinesterase(Ache) in CNS. It significantly enhances cognitive functions of Alzheimer’s patients and has been approved for the treatment of Alzheimer’s disease in Europe and USA. Searching for more potent inhibitors of Ache, considerable effort is directed toward its synthesis and derivatization, as it is much less toxic than other inhibitors including physostigmine and tacrine. Envisioned that the cycloadduct of properly substituted 2-pyrone can readily provide the core structure of galanthamine, we set out to investigate the total synthesis of galanthamine, using the regioselective coupling reactions of 3,5-dibromo-2-pyrone and subsequent IMDA cycloaddition reactions as key steps | - |
| dc.title | Total synthesis of (±)-galanthamine and related natural products with the regioselective Pd-catalyzed coupling reactions of 3,5-dibromo-2-pyrone | - |
| dc.type | Conference | - |
| dc.citation.conferenceName | 제97회-2006년 춘계대한화학회 | - |
| dc.citation.conferencePlace | 고양시한국국제전시장 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
